carboplatin,etoposide,atezolizumab,tiragolumab
roche
['skyscraper-02', 'tiragolumab', 'sclc']
skyscraper-02 unfortunately no effect in pfs or interim os of adding tiragolumab (anti-tigit) to chemo-io in extended sclc #asco2022 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????